(Source: Business Wire)

Organized by IQPC,
the 5th
Forum on Laboratory Informatics will be held October 26-28, 2009
in San Francisco, California (www.labinformaticsforum.com).
This forum addresses the fundamental challenges of lab system
integration and interfacing, and is geared towards pharmaceutical and
biotech professionals involved in informatics, lab operations, research
& development, data management and software development.
Recent company mergers in the pharmaceutical industry have brought to
light the need for efficient collection, organization and consolidation
of data and information, which is even more challenging when systems are
integrated. Overwhelming amounts of accumulated data requires proper
management from the right systems and this remains a difficulty for many
labs.
Leaders from Pfizer, Johnson & Johnson, Eli Lilly,
Millennium (the Takeda Oncology Company), Allergan Pharmaceuticals,
Genentech, PhaseFour Informatics, SmarterLab, Atrium Research &
Consulting will be discussing:
Regulatory compliance and meeting FDA expectations
ELN and LIMS selection, evaluation and deployment with a focus on ROI
and the impact on business performance
Ensuring data quality and validation through electronic record
management
Overcoming interfacing and integration issues when using software and
instruments from various vendors
Sponsors of the 5th Forum on Lab Informatics include Waters
Laboratory Informatics, CambridgeSoft and CSols Inc.
For more information on the 5th Forum on Laboratory
Informatics, visit www.labinformaticsforum.com
or contact Abby Lombardi at abby.lombardi@iqpc.com
or +1 212-885-2660.
About IQPC
IQPC (www.iqpc.com)
provides business executives with tailored practical conferences,
large-scale events, topical seminars and in-house training programs.
Producing over 1,500 events annually around the world, IQPC continues to
grow and has offices in cities across six continents including: Berlin,
Dubai, London, New York, Sao Paulo, Singapore, Stockholm, Sydney, and
Toronto.
A service of YellowBrix, Inc.